Graham Dixon

Graham K.
Dixon is currently Chief Executive Officer at Estetra SRL, Chairman at Apaxen SA, Director at InteRNA Technologies BV, Chief Scientific Officer at Mithra Pharmaceuticals SA, Member of the Supervisory Board at Formycon AG, and Head of Research & Development at Zaluvida Holdings Pte Ltd. Former roles include Chief Executive Officer at Neem Biotech Ltd., Chairman at HepaRegeniX GmbH from 2017 to 2022, Independent Director at Alligator Bioscience AB from 2019 to 2024, Head of Research & Development at AstraZeneca PLC from 1994 to 2002, Senior Vice President of Drug Discovery at Lakefront Biotherapeutics from 2004 to 2012, CSO and Head of Research & Development at Valerio Therapeutics SA from 2015 to 2017, Head of Research & Development at Zeneca Garden Care from 1994 to 2002, Chief Scientific Officer at Galapagos Genomics NV, CSO and Head of Research & Development at Addex Therapeutics Ltd., Chief Scientific Officer at Entomed SA, Chief Scientific Officer at F2G Ltd. from 2002 to 2003, and CSO and Head of Research & Development at Sensorion SA. Education includes undergraduate studies at the University of Bradford and a doctorate from Swansea University.